CAMP4 Therapeutics Corpor...

NASDAQ: CAMP · Real-Time Price · USD
1.67
0.12 (7.74%)
At close: Aug 15, 2025, 3:59 PM
1.70
2.08%
After-hours: Aug 15, 2025, 07:52 PM EDT

CAMP4 Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is March - February.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Nov 30, 2023 Aug 31, 2023 May 31, 2023 Feb 28, 2023 Nov 30, 2022 Aug 31, 2022 May 31, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020 May 31, 2020
Net Income
-51.77M -51.79M -51.5M -49.71M -41.17M -36.81M -28.55M -24.35M -32.49M -33.58M -39.39M -37.32M -31.15M 4.46M -8.68M -12.73M -21.16M -103.41M -87.14M -85.03M
Depreciation & Amortization
1.68M 1.7M 1.71M 1.73M 6.85M 12.07M 16.85M 21.81M 21.76M 21.82M 22.57M 22.82M 22.8M 18.49M 19.4M 20.68M 22M 28.85M 30.31M 31.9M
Stock-Based Compensation
4.04M 4.03M 3.87M 3M 4.39M 5.56M 6.96M 9.43M 10.21M 10.95M 12.07M 11.81M 11.32M 10.43M 10.3M 10.21M 11.36M 12.54M 13.16M 13.5M
Other Working Capital
-4M -1.5M -2.81M 92K 233K 2.6M 2.98M -591K -1.91M -6.57M -10.66M -14.08M -14.23M -14.42M -10.48M -4.51M -6.2M -4.21M -2.48M -3.02M
Other Non-Cash Items
1.95M 1.79M 1.76M 1.69M 1.99M 2.09M 2.33M 2.27M 1.98M 4.57M 6.43M 8.36M 10.15M 4.66M 4.54M 4.54M 4.82M 9.12M 8.91M 12.12M
Deferred Income Tax
-480K -480K n/a n/a -304K 240K 243K 263K 676K 208K 344K 411K 465K 16K 354K 13K -1K 24.63M 21.88M 20.86M
Change in Working Capital
-4.64M -1.33M -1.94M 334K -4.22M -5.56M -4.62M -19.79M -25.07M -33.33M -42.37M -25.92M -17.42M -4.16M 7.34M 8.06M 14.93M 18.92M 12.58M 2.48M
Operating Cash Flow
-52.69M -49.54M -46.06M -42.92M -32.46M -22.41M -6.79M -10.36M -22.93M -29.37M -40.34M -19.85M -4.22M 7.55M 24.91M 22.72M 28.59M 32.58M 26.05M 23.04M
Capital Expenditures
-705K -441K -421K -628K -2.42M -4.21M -8.37M -9.43M -11.1M -12.25M -11.62M -13.84M -13.3M -10.61M -10.36M -11.36M -11.36M -15.64M -19.04M -20.33M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -548K -548K 1.83M
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.26M -6.26M -8.19M -15.97M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.26M 8.19M 15.98M 25.81M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -207K 691K 694K
Investing Cash Flow
-705K -441K -421K -628K -2.42M -4.21M -8.37M -9.43M -11.1M -12.25M -12.52M -14.73M -7.58M -7.22M -6.08M -7.08M -13.69M -14.47M -11.1M -7.97M
Debt Repayment
-311K -364K -389K -388K -299K -210K -89K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-4.33M -4.33M -1.11M -895K -429K -504K -669K -1.7M -1.86M -1.72M -1.72M -3.54M -4.17M -4.2M -4.1M -2.55M -1.63M -1.74M -1.82M -1.92M
Financial Cash Flow
71.71M 71.66M -1.46M -1.28M -725K -259K -303K -741K -909K -588K -592K -2.25M -2.64M -2.24M -22.2M -20.42M -27.32M -27.66M -102.32M -102.41M
Net Cash Flow
22.3M 25.66M -47.94M -44.83M -37.38M -29M -19.73M -12.76M -5.79M -2.81M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Free Cash Flow
-49.41M -46M -46.48M -43.55M -34.88M -26.62M -15.16M -19.79M -34.03M -41.62M -51.96M -33.68M -17.52M -3.05M 14.55M 11.36M 17.23M 16.94M 7.01M 2.71M